Several analysts have recently updated their ratings and price targets for FedEx (NYSE: FDX): 12/1/2025 – FedEx had its price target raised by analysts at BMO Capital Markets from $255.00 to $265.00. They now have a “market perform” rating on the stock. 11/26/2025 – FedEx had its “hold (c+)” rating reaffirmed by analysts at Weiss […]

Several brokerages have updated their recommendations and price targets on shares of LyondellBasell Industries (NYSE: LYB) in the last few weeks: 11/22/2025 – LyondellBasell Industries was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating. 11/19/2025 – LyondellBasell Industries had its price target lowered by analysts at Citigroup Inc. […]

Lam Research (NASDAQ: LRCX) recently received a number of ratings updates from brokerages and research firms: 11/25/2025 – Lam Research had its “buy” rating reaffirmed by analysts at UBS Group AG. They now have a $175.00 price target on the stock, up previously from $165.00. 11/24/2025 – Lam Research had its “buy (b)” rating reaffirmed […]

A number of firms have modified their ratings and price targets on shares of Arrowhead Pharmaceuticals (NASDAQ: ARWR) recently: 11/26/2025 – Arrowhead Pharmaceuticals had its price target raised by analysts at Morgan Stanley from $45.00 to $48.00. They now have an “equal weight” rating on the stock. 11/20/2025 – Arrowhead Pharmaceuticals had its price target […]

A number of firms have modified their ratings and price targets on shares of ODDITY Tech (NASDAQ: ODD) recently: 11/22/2025 – ODDITY Tech was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating. 11/21/2025 – ODDITY Tech had its price target lowered by analysts at JPMorgan Chase & Co. […]

Stoke Therapeutics (NASDAQ: STOK) has recently received a number of price target changes and ratings updates: 11/19/2025 – Stoke Therapeutics had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – Stoke Therapeutics was upgraded by analysts at Chardan Capital to a “strong-buy” rating. 11/13/2025 – Stoke Therapeutics had its “hold (c-)” rating […]

MGE Energy (NASDAQ: MGEE) has recently received a number of price target changes and ratings updates: 11/25/2025 – MGE Energy had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – MGE Energy was downgraded by analysts at Weiss Ratings from a “buy (b-)” rating to a “hold (c+)” rating. 11/13/2025 – MGE […]

A number of firms have modified their ratings and price targets on shares of Halozyme Therapeutics (NASDAQ: HALO) recently: 11/19/2025 – Halozyme Therapeutics had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings. 11/18/2025 – Halozyme Therapeutics had its price target raised by analysts at The Goldman Sachs Group, Inc. from $54.00 to $56.00. […]

Several brokerages have updated their recommendations and price targets on shares of Nutanix (NASDAQ: NTNX) in the last few weeks: 11/26/2025 – Nutanix had its price target lowered by analysts at Northland Securities from $76.00 to $53.00. They now have a “market perform” rating on the stock. 11/26/2025 – Nutanix had its price target lowered […]

Trade Desk (NASDAQ: TTD) has recently received a number of price target changes and ratings updates: 11/25/2025 – Trade Desk had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – Trade Desk had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/13/2025 – Trade Desk had its “hold (c-)” rating […]

PTC Therapeutics (NASDAQ: PTCT) recently received a number of ratings updates from brokerages and research firms: 11/25/2025 – PTC Therapeutics had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – PTC Therapeutics had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 11/13/2025 – PTC Therapeutics had its “hold (c)” rating […]